ArticleEBioMedicine2026

Integrated proteomic and immune subtyping: a two-tier framework for biomarker-guided therapy in high-grade serous ovarian cancer.

Jiagui Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.